Your browser doesn't support javascript.
loading
Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression.
Chandrasekaran, Sanjay; Sasaki, Maiko; Scharer, Christopher D; Kissick, Haydn T; Patterson, Dillon G; Magliocca, Kelly R; Seykora, John T; Sapkota, Bishu; Gutman, David A; Cooper, Lee A; Lesinski, Gregory B; Waller, Edmund K; Thomas, Susan N; Kotenko, Sergei V; Boss, Jeremy M; Moreno, Carlos S; Swerlick, Robert A; Pollack, Brian P.
Afiliação
  • Chandrasekaran S; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.
  • Sasaki M; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.
  • Scharer CD; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia.
  • Kissick HT; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia.
  • Patterson DG; Winship Cancer Institute of Emory University School of Medicine, Atlanta, Georgia.
  • Magliocca KR; Department of Urology Emory University School of Medicine, Atlanta, Georgia.
  • Seykora JT; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia.
  • Sapkota B; Winship Cancer Institute of Emory University School of Medicine, Atlanta, Georgia.
  • Gutman DA; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Cooper LA; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Lesinski GB; Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Waller EK; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.
  • Thomas SN; Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia.
  • Kotenko SV; Department of Neurology, Emory University School of Medicine, Atlanta, Georgia.
  • Boss JM; Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, Georgia.
  • Moreno CS; Department of Biomedical Engineering, Georgia Institute of Technology, George W. Woodruff School of Mechanical Engineering, Atlanta, Georgia.
  • Swerlick RA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.
  • Pollack BP; Winship Cancer Institute of Emory University School of Medicine, Atlanta, Georgia.
Mol Cancer Res ; 17(12): 2395-2409, 2019 12.
Article em En | MEDLINE | ID: mdl-31548239
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon gama / Fator de Transcrição STAT1 / Fosfatidilinositol 3-Quinase / Carcinoma de Células Escamosas de Cabeça e Pescoço Limite: Humans Idioma: En Revista: Mol Cancer Res Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Geórgia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon gama / Fator de Transcrição STAT1 / Fosfatidilinositol 3-Quinase / Carcinoma de Células Escamosas de Cabeça e Pescoço Limite: Humans Idioma: En Revista: Mol Cancer Res Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Geórgia